FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.0  |  FHIR Version n/a  User: [n/a]

9504011000001102: Zavesca 100mg capsules (Janssen-Cilag Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1389241000001118 Zavesca 100mg capsules (Janssen-Cilag Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1389251000001115 Zavesca 100mg capsules (Janssen-Cilag Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
31012501000001112 Zavesca 100mg capsules (Actelion Pharmaceuticals UK Ltd) (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
31012601000001111 Zavesca 100mg capsules (Actelion Pharmaceuticals UK Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zavesca 100mg capsules (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zavesca 100mg capsules (Janssen-Cilag Ltd) Is a Product containing precisely miglustat 100 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Zavesca 100mg capsules (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Zavesca 100mg capsules (Janssen-Cilag Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zavesca 100mg capsules (Janssen-Cilag Ltd) Has active ingredient Substance with enzyme mechanism of action false Inferred relationship Existential restriction modifier
Zavesca 100mg capsules (Janssen-Cilag Ltd) Has active ingredient Miglustat false Inferred relationship Existential restriction modifier
Zavesca 100mg capsules (Janssen-Cilag Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zavesca 100mg capsules (Janssen-Cilag Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zavesca 100mg capsules (Janssen-Cilag Ltd) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Zavesca 100mg capsules (Janssen-Cilag Ltd) Is a Zavesca true Inferred relationship Existential restriction modifier
Zavesca 100mg capsules (Janssen-Cilag Ltd) Has specific active ingredient Miglustat true Inferred relationship Existential restriction modifier
Zavesca 100mg capsules (Janssen-Cilag Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Zavesca 100mg capsules (Janssen-Cilag Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Zavesca 100mg capsules (Janssen-Cilag Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zavesca 100mg capsules (Janssen-Cilag Ltd) 84 capsule 4 x 21 capsules Is pack of False Zavesca 100mg capsules (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier
Zavesca 100mg capsules (Janssen-Cilag Ltd) 84 capsule 4 x 21 capsules Has AMP True Zavesca 100mg capsules (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start